What is BeyondSpring Inc. (BYSI)?
BeyondSpring Inc. is a clinical-stage biopharmaceutical company engaged in the discovery, development, and commercialization of novel therapies for cancer treatment. The company focuses on small molecule drugs targeting mechanisms involved in tumor growth and resistance. BeyondSpring's pipeline includes candidates aimed at hematologic malignancies and solid tumors. It employs research and development strategies that combine preclinical studies with clinical trials to advance its therapeutic candidates. The company collaborates with academic institutions and industry partners to enhance its drug development efforts. BeyondSpring seeks to address unmet medical needs by developing treatments that improve patient outcomes in oncology.
BeyondSpring Inc. Stock Price Today: Live Overview
The price today is shaped by the market's trading dynamics for BeyondSpring Inc., with a current price of $1.6737. Its price has fluctuated between $1.6463 and $1.6563 during the session, reflecting a daily change percentage of +1.8561%.
FAQ: BeyondSpring Inc. (BYSI)
What is the current price of BYSI stock?
The current price is $1.6737.
Does BYSI pay dividends?
BeyondSpring Inc. does not pay dividends.
Does BYSI have a formal corporate presence or regional headquarters in the UAE?
BeyondSpring Inc. has no official presence in the UAE and operates through partners.
What is BYSI best known for?
BeyondSpring Inc. is most famous for its development of oncology drug candidates.
What assets are typically shown together with BYSI?
Commonly shown alongside BYSI: Powell Industries, Bilia, Xtrackers S&P 500 ESG ETF
Latest shares articles



